Bill Young, I'm Chairman of the Board of Biogen Idec and will act as Chairman of the meeting, which is now called to order.
In attendance are Susan Alexander, Executive Vice President, Chief Legal Officer and Secretary of Biogen Idec, who will act as Secretary of the meeting; and George Scangos, Chief Executive and Director, who will make a presentation following a conclusion of the formal portion of the meeting. Other members of our Board of Directors who are in attendance today are Alex Denner, Caroline Dorsa, Nancy Leaming, Richard Mulligan, Stelios Papadopoulos, Brian Posner, Eric Rowinsky, Lynn Schenk and Stephen Sherwin. Several of our other executive officers are also in attendance, including Paul Clancy, Chief Financial Officer; John Cox, Executive Vice President of Pharmaceutical Operations and Technology; Ken DiPietro, Executive Vice President of Human Resources; Steve Holtzman, Executive Vice President of Corporate Development; Tony Kingsley, Executive Vice President of Global Commercial Operations; Ray Pawlicki, Senior Vice President and Chief Information Officer; Doug Williams, Executive Vice President of Research and Development; and Spyros Artavanis, Chief Scientific Officer. Jim Connolly of PricewaterhouseCoopers, our independent auditor, is also present and is available to answer questions -- any questions that you might have for him.